Overexpression of protein disulfide isomerase enhances vitamin K epoxide reductase activity.

antagoniste de la vitamine K cycle de la vitamine K protein disulfide-isomerases protéine disulfure-isomérase reduction réduction vitamin K antagonist vitamin K cycle vitamin K epoxide reductase vitamine K époxyde réductase

Journal

Biochemistry and cell biology = Biochimie et biologie cellulaire
ISSN: 1208-6002
Titre abrégé: Biochem Cell Biol
Pays: Canada
ID NLM: 8606068

Informations de publication

Date de publication:
04 2022
Historique:
pubmed: 11 1 2022
medline: 5 4 2022
entrez: 10 1 2022
Statut: ppublish

Résumé

Vitamin K epoxide reductase (VKOR) activity is catalyzed by the VKORC1 enzyme. It is a target of vitamin K antagonists (VKA). Numerous mutations of VKORC1 have been reported and are suspected to confer resistance to VKA and (or) affect its velocity. Nevertheless, the results of these studies have been conflicting, and the functional characterization of these mutations in the cell system is complex because of the interweaving of VKOR activity in the vitamin K cycle. In this study, a new cellular approach was implemented to evaluate the vitamin K cycle in HEK293 cells. This global approach was based on the vitamin K quinone/vitamin K epoxide (K/KO) balance. In the presence of VKA or when VKORC1 and VKORC1L1 were knocked out, the K/KO balance decreased significantly due to the accumulation of vitamin KO. In contrast, when VKORC1 was overexpressed, the balance remained unchanged, demonstrating the limitation of VKOR activity. This limitation was shown to be due to insufficient expression of the activation partner of VKORC1, as overexpression of protein disulfide isomerase (PDI) overcomes this limitation. This study is the first to demonstrate the functional interaction between VKORC1 and PDI.

Identifiants

pubmed: 35007172
doi: 10.1139/bcb-2021-0441
doi:

Substances chimiques

Anticoagulants 0
Vitamin K 12001-79-5
VKORC1 protein, human EC 1.17.4.4
Vitamin K Epoxide Reductases EC 1.17.4.4
Protein Disulfide-Isomerases EC 5.3.4.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

152-161

Auteurs

Thomas Chetot (T)

USC 1233 RS2GP, VetAgro Sup, INRAE, University of Lyon, 69280, Marcy L'Etoile, France.
USC 1233 RS2GP, VetAgro Sup, INRAE, University of Lyon, 69280, Marcy L'Etoile, France.

Etienne Benoit (E)

USC 1233 RS2GP, VetAgro Sup, INRAE, University of Lyon, 69280, Marcy L'Etoile, France.
USC 1233 RS2GP, VetAgro Sup, INRAE, University of Lyon, 69280, Marcy L'Etoile, France.

Véronique Lambert (V)

USC 1233 RS2GP, VetAgro Sup, INRAE, University of Lyon, 69280, Marcy L'Etoile, France.
USC 1233 RS2GP, VetAgro Sup, INRAE, University of Lyon, 69280, Marcy L'Etoile, France.

Virginie Lattard (V)

USC 1233 RS2GP, VetAgro Sup, INRAE, University of Lyon, 69280, Marcy L'Etoile, France.
USC 1233 RS2GP, VetAgro Sup, INRAE, University of Lyon, 69280, Marcy L'Etoile, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH